The aim of this study is to investigate the effect of daily treatment with Indapamide for 14 days on urinary calcium excretion in patients with post surgical hypoparathyroidisme.
The aim of this study is to investigate the effect of daily treatment with Indapamide for 14 days on urinary calcium excretion in patients with post surgical hypoparathyroidisme. Patients will do weekly blood sampling and 24 hour urine collection every second week.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Enrollment
24
14 days treatment with indapamide 1.5 mg/day compared to placebo
14 days treatment with placebo
Department of Endocrinology and Internal Medicine
Aarhus, Denmark
RECRUITINGUrinary calcium excretion
investigate the effect of daily treatment with Indapamide for 14 days compared to placebo on urinary calcium excretion in patients with chronic post-surgical hypoparathyroidism
Time frame: Day 15
Ionized calcium
To assess if treatment with Indapamide can affect the level of ionized calcium in the blood during treatment with Indapamide and hereby reduce the need for supplementation with oral calcium and active vitamin D.
Time frame: Day 15
Sodium diet
assess the efficacy of a low sodium diet in the placebo period on plasma ionized calcium and on the 24-hour urinary calcium excretion in patients with hypoparathyroidism
Time frame: Day 15
Safety (blood pressure)
To assess the safety (blood pressure) of daily treatment with Indapamide for 14 days compared to placebo
Time frame: Day 15
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.